Cargando…
Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells
Therapeutic advances have markedly prolonged overall survival in multiple myeloma (MM) but the disease currently remains incurable. In a panel of MM cell lines (MM.1S, OPM-2, H929, and U266), using CD138 immunophenotyping, side population staining, and stem cell-related gene expression, we demonstra...
Autores principales: | Schibler, Jeanine, Tomanek-Chalkley, Ann M., Reedy, Jessica L., Zhan, Fenghuang, Spitz, Douglas R., Schultz, Michael K., Goel, Apollina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130279/ https://www.ncbi.nlm.nih.gov/pubmed/27902770 http://dx.doi.org/10.1371/journal.pone.0167323 |
Ejemplares similares
-
Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis
por: Andreev-Andrievskiy, Alexander A., et al.
Publicado: (2016) -
Copper–zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma
por: Salem, Kelley, et al.
Publicado: (2014) -
Decylammonium octanoate
por: Jefferson, Andrew E., et al.
Publicado: (2011) -
Pentadecylammonium methyl sulfate
por: Zhang, Lijun, et al.
Publicado: (2011) -
Enhancement of clonogenicity of human multiple myeloma by dendritic cells
por: Kukreja, Anjli, et al.
Publicado: (2006)